当前位置:首页 - 行情中心 - 艾迪药业(688488) - 财务分析 - 资产负债表

艾迪药业

(688488)

  

流通市值:54.20亿  总市值:54.20亿
流通股本:4.21亿   总股本:4.21亿

资产负债表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
流动资产:
货币资金422,725,438.85335,339,509.95337,145,466216,580,377.54
应收票据及应收账款156,174,691.95152,031,473.62165,566,947.32208,214,672.43
其中:应收票据28,829,134.7812,890,146.5917,006,391.454,874,528.01
应收账款127,345,557.17139,141,327.03148,560,555.87203,340,144.42
应收款项融资6,874,888.8810,893,172.412,188,866.535,934,327.58
预付款项8,425,288.745,600,780.3229,538,789.0826,974,598.04
其他应收款合计21,389,848.1720,915,633.776,800,809.53,703,055.05
存货271,741,947.75254,971,935.86244,631,202.62210,988,009.39
其他流动资产5,567,294.298,995,467.145,565,664.928,896,148.75
流动资产平衡项目0000
流动资产合计923,045,501.19894,931,610.09936,664,740.84796,581,825.9
非流动资产:
长期股权投资1,299,832.17--100,084,987.24
其他非流动金融资产78,734,332.2969,598,10082,140,567.9865,528,366.42
固定资产416,738,470.28424,195,808.58432,623,144.58420,207,435.39
在建工程1,409,380.532,175,929.2151,282.37489,729.63
使用权资产6,990,077.468,076,312.159,012,585.245,482,253.66
无形资产170,506,891.66175,465,377.26111,189,264.97108,977,523.75
开发支出8,713,678.524,940,435.1767,535,755.4578,065,858.28
商誉171,616,799.19171,616,799.19171,375,510.6913,239,342.66
长期待摊费用30,337,808.7131,472,080.531,408,929.156,479,762.2
递延所得税资产82,637,537.2783,853,709.9875,897,388.5265,518,596.54
其他非流动资产3,075,7503,237,176.210,256,821.57,883,294.31
非流动资产平衡项目0000
非流动资产合计972,060,558.08974,631,728.23991,591,250.45871,957,150.08
资产平衡项目0000
资产总计1,895,106,059.271,869,563,338.321,928,255,991.291,668,538,975.98
流动负债:
短期借款280,134,871.79220,504,209.85214,485,433.35215,496,733.35
应付票据及应付账款135,820,243.8113,262,305.9394,848,911.9698,974,494.64
其中:应付票据32,327,691.3424,394,310.9814,882,479.5222,041,661.7
应付账款103,492,552.4688,867,994.9579,966,432.4476,932,832.94
合同负债9,751,471.0313,082,552.617,095,602.81,623,737.87
应付职工薪酬12,324,020.7119,364,625.4817,614,850.747,089,617.51
应交税费10,210,141.917,932,207.8712,283,152.053,122,372.81
其他应付款合计82,640,082.8782,170,33890,608,441.814,677,094.46
一年内到期的非流动负债114,629,766.14173,268,842.19172,062,945.09172,947,007.58
其他流动负债11,318,393.9819,474,328.2312,670,978.82,628,769.3
流动负债平衡项目0000
流动负债合计656,828,992.23649,059,410.16621,670,316.59516,559,827.52
非流动负债:
长期借款83,331,00090,508,00090,558,0009,890,000
租赁负债3,736,001.943,745,262.876,266,587.892,871,082.38
递延收益48,338,338.9749,736,352.0645,018,927.9248,658,521.57
递延所得税负债10,408,708.369,427,038.0512,146,359.046,704,537.88
非流动负债平衡项目0000
非流动负债合计145,814,049.27153,416,652.98153,989,874.8568,124,141.83
负债平衡项目0000
负债合计802,643,041.5802,476,063.14775,660,191.44584,683,969.35
所有者权益(或股东权益):
实收资本(或股本)420,782,808420,782,808420,782,808420,782,808
资本公积883,622,921.25883,622,921.25891,703,345.55892,099,701.17
其他综合收益549,789.4549,789.4549,789.4549,789.4
专项储备1,166,627.711,286,382.541,330,700.21-
盈余公积9,307,578.939,307,578.939,307,578.939,307,578.93
未分配利润-319,072,605.28-334,654,581.53-254,391,916.47-238,884,870.87
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计996,357,120.01980,894,898.591,069,282,305.621,083,855,006.63
少数股东权益96,105,897.7686,192,376.5983,313,494.23-
股东权益平衡项目0000
股东权益合计1,092,463,017.771,067,087,275.181,152,595,799.851,083,855,006.63
负债和股东权益合计1,895,106,059.271,869,563,338.321,928,255,991.291,668,538,975.98
公告日期2025-04-302025-04-302024-10-312024-08-23
审计意见(境内)标准无保留意见
TOP↑